Ending Cancer Health Disparities Through Increased Collaboration
Despite tremendous progress against cancer in the past few decades, not all Americans have benefited equally from advances in...
Starting the Conversation: Panel Discusses National Black Family Cancer Awareness Week
Karriem Watson is a public health expert serving as chief engagement officer of the National Institutes of Health’s All...
AACR Project GENIE® Contributes Data to Global Hackathon
The term “hackathon” may conjure up images of beanie-wearing coders working in dark basements, trying to build a new...
AACR Releases Cancer Progress Report 2021
On Wednesday, the American Association for Cancer Research (AACR) released its annual Cancer Progress Report. Now in its 11th year, the report details advances in the cancer research...
Turning Cancer Disparities Research Into Action
In 2008, Robin Evans received a devastating diagnosis: stage 4 metastatic triple-negative breast cancer. This subtype of breast cancer,...
How Community Outreach Can Increase Access to Colorectal Cancer Screening in Underserved Populations
Like most cancers, colorectal cancer (CRC) is easier to treat before it spreads to other organs. When caught in its earliest stages, the five-year relative...
AACR Meetings Feature Latest Advances in Blood Cancer Research
Cancers of the blood can initiate in a variety of cells, including in white blood cells (giving rise to lymphoma and leukemia) or in plasma cells...
AACR and ASCO Call for a Prohibition on Flavored E-Cigarettes
By Nicholas Warren, PhD Today, the American Association for Cancer Research (AACR) and the American Society of Clinical Oncology...
Annual Meeting 2022: A New AACR Task Force to Promote Public Trust in Science
The COVID-19 pandemic has provided a strong reminder for the scientific community about the importance of public understanding and...
AACR Annual Meeting 2021: A Recap of Blog Posts
The AACR Annual Meeting 2021 featured the theme “Discovery Science Driving Clinical Breakthroughs.” Indeed, over the course of two weeks,...
Personalized Neoantigen Vaccines Boost Progress Against Aggressive Cancers
Researchers at the AACR Annual Meeting 2024 presented the latest findings regarding two personalized neoantigen cancer vaccines.
AACR Virtual Annual Meeting I: The Promises and Challenges of Expanding the Use of Immune Checkpoint Inhibitors Through Combination Therapy
The cutting-edge scientific program for the AACR Virtual Annual Meeting I began Monday, April 27, with an Opening Clinical Plenary featuring...
AACR-Cancer Research UK Transatlantic Fellowships: Inaugural Recipients Announced
The strategic alliance between the American Association for Cancer Research (AACR) and Cancer Research UK (CRUK) includes support for...
AACR Dialogues Spark Important Conversations About Cancer
In the ongoing quest to end cancer health disparities, there’s a simple tool that virtually anyone can use: honest...
NIH-AACR Cancer, Autoimmunity, and Immunology Conference: A Virtual, Multidisciplinary Forum on Immune-related Adverse Events
By Meghali Goswami Meghali Goswami is a PhD candidate in the George Washington University – National Institutes of Health Graduate Partnerships Program and is currently...
Interfacing with the Future: Artificial Intelligence in Oncology
Researchers discussed AI's impact on the diagnosis and treatment of cancer at the AACR Annual Meeting 2024.
AACR Annual Meeting 2023: Clinical Trials of Therapeutic Cancer Vaccines Show Promise
The concept of using vaccination to eradicate cancer by instructing the immune system to eliminate malignant cells has been...
The Best of 2022: FDA Approvals and the Breakthroughs That Enabled Them
The end of the year presents a unique opportunity to look back on recent accomplishments, take inventory of successes...
AACR Virtual Annual Meeting I: Results Presented Provide Basis for FDA Decision to Approve Alternative Pembrolizumab Dosing Schedule
A short time after Mallika Lala, PhD, finished her presentation titled “Pembrolizumab 400 mg Q6W dosing: First clinical outcomes...
Annual Meeting 2022: Advancing Precision Immuno-oncology
“The immuno-oncology revolution is now about 15 years into clinical reality,” said Carl June, MD, FAACR, director of the...
AACR Journal Editors Share “Must Read” Articles for March
While COVID-19 is at the center of medical news, important cancer research findings continue to be reported. As March...
Disparities Conference Unites Researchers, Patients, and Policymakers
As the 15th AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved...
New Journal Article Explores Equity in Academia
As the murders of George Floyd, Breonna Taylor, and others exposed racial inequities in America, many sectors of society...
Crystal Mackall: Expanding the Reach of CAR T-cell Therapy
For the sixth time since 2015, researchers, clinicians, drug developers, patient advocates, and other stakeholders convened at the International...
Annual Meeting 2022: Uniting Scientists and Survivors
For more than 20 years, the Scientist↔Survivor Program (SSP) has played a vital role in the American Association for...
Frontiers in Cancer Science: A Stellar Conference in Singapore
by Ashok Venkitaraman, MBBS, PhD Singapore will hold its 15th Frontiers in Cancer Science (FCS) conference November 6-8 at...
Colonoscopy: A Powerful Tool for Cancer Prevention
Guest post by Raymond N. DuBois, MD, PhD, FAACR The headlines stunned many medical professionals, cancer patients, and colorectal...
Addressing Racial Disparities in Multiple Myeloma Clinical Trials and Outcomes During the Pandemic
The word myeloma stems from the Greek word “myelos,” for marrow. Indeed, this type of blood cancer begins in the plasma cells, a type...
Frontiers in Cancer Science—the Singapore Cancer Conference
Guest post by Patrick Casey, PhD, and Joanne Ngeow, BMedSci, MBBS, FRCP, MPH From November 7-9, 2022, Singapore will...
Advances in Malignant Lymphoma Virtual Meeting: Stratifying Risk, Targeting Precursor Cells, Hacking the Epigenome, and More
Virtual scientific meetings have become the “new normal” in the COVID-19 era, enabling researchers to present and discuss recent...